FDA Inspection
Blood Bank Of Delmarva, A Division of New York Blood CenterBlood Bank Of Delmarva, A Division of New York Blood Center – FDA Inspection, Aug 16, 2018
Record Details
This FDA Inspection record concerns Blood Bank Of Delmarva, A Division of New York Blood Center, with an inspection on August 16, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- August 16, 2018
- Product Type
- Biologics
View Company Profile
ID · 34627864-27e4-4158-a749-25b60d529779
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1063784
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Blood Bank Of Delmarva, A Division of New York Blood Center
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 2, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 19, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 2, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 27, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 29, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Blood Bank Of Delmarva, A Division of New York Blood Center
- FDA Inspection 1153969 - 2021-08-02
- FDA Inspection 952594 - 2015-11-19
- FDA Inspection 893580 - 2014-09-02
- FDA Inspection 793243 - 2012-06-27
- FDA Inspection 699792 - 2010-11-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.